Benitec Biopharma Inc. Quarterly Depreciation in USD from Q3 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Benitec Biopharma Inc. quarterly/annual Depreciation history and growth rate from Q3 2019 to Q3 2023.
  • Benitec Biopharma Inc. Depreciation for the quarter ending September 30, 2023 was $19K, a 54.8% decline year-over-year.
  • Benitec Biopharma Inc. annual Depreciation for 2022 was $167K, a 27.7% decline from 2021.
  • Benitec Biopharma Inc. annual Depreciation for 2021 was $231K, a 413% increase from 2020.
  • Benitec Biopharma Inc. annual Depreciation for 2020 was $45K, a 71.5% decline from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $19K -$23K -54.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q3 2022 $157K $42K -$10K -19.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $167K $6K -$46K -88.5% Apr 1, 2022 Jun 30, 2022 10-K 2022-09-02
Q1 2022 $213K $54K -$13K -19.4% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $226K $55K -$12K -17.9% Oct 1, 2021 Dec 31, 2021 10-Q 2022-02-14
Q3 2021 $238K $52K +$7K +15.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $231K $52K +$157K Apr 1, 2021 Jun 30, 2021 10-K 2022-09-02
Q1 2021 $74K $67K +$19K +39.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $55K $67K +$16K +31.4% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $39K $45K -$6K -11.8% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $45K -$105K Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 $48K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $51K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 $51K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.